Lund — 2 February 2017 — Camurus (CAMX) today announces that Fredrik Tiberg, President and CEO, will provide an overview and update on the company's business at the Cowen and Company 37th Annual Healthcare Conference in Boston, Massachusetts. The presentation and the following Q&A session will take place on Tuesday 7 March 2017 at 8:00 am Eastern Standard Time and can be accessed via a live webcast at Camurus website www.camurus.com. An archived version of the webcast will be available for 90 days after the event.
Camurus is a Swedish research-based pharmaceutical company committed to developing and commercialising innovative and differentiated medicines for the treatment of severe and chronic conditions. New drug products with best-in-class potential are conceived based on the proprietary FluidCrystal® drug delivery technologies and an extensive R&D expertise. Camurus’ clinical pipeline includes products for treatment of cancer, endocrine diseases, pain and addiction, developed in-house and in collaboration with international pharmaceutical companies. The company’s shares are listed on Nasdaq Stockholm under the ticker “CAMX”. For more information, visit www.camurus.com.
For more information
Fredrik Tiberg, President & CEO
Tel. +46 (0)46 286 46 92
Rein Piir, VP Investor Relations
Tel. +46 (0)70 853 72 92
The information was submitted for publication at 13.00 a.m. on 2 February 2017.